Back

Cerevel Therapeutics Holdings Stock Predictions

$1,300 into $45,000 in just 4 MONTHS?!

See here to see the full details.

Buy

CERE
Cerevel Therapeutics Holdings

Last Price:

44.62

Seasonality Move:

12.94%

7 Day Trial

ALL ACCESS PASS

$ 7

Wall Street's Worst Nightmare: Small Town Trader's AI Edge

See the AI advantage for everyday Americans.

Cerevel Therapeutics Holdings Stock Forecast

Over the next 52 weeks, Cerevel Therapeutics Holdings has on average historically risen by 22% based on the past 3 years of stock performance.
Cerevel Therapeutics Holdings has risen higher in 3 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
Is Cerevel Therapeutics Holdings Stock Undervalued?
The current Cerevel Therapeutics Holdings [CERE] share price is $44.39. The Score for CERE is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
CERE is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.

Will Cerevel Therapeutics Holdings Stock Go Up Next Year?

Over the next 52 weeks, Cerevel Therapeutics Holdings has on average historically risen by 22% based on the past 3 years of stock performance.

Cerevel Therapeutics Holdings Stock Rating

Buy

Cerevel Therapeutics Holdings (CERE) is a Buy

Is Cerevel Therapeutics Holdings overpriced?

Cerevel Therapeutics Holdings has risen higher in 3 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%

Cerevel Therapeutics Holdings Stock Price History

Is CERE stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CERE is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

cerevel.com

52-Week Data

52-Week High:

44.54

52-Week Low:

19.59

Prediction Charts

Market Cap:

8.09B

Price in USD:

44.39

Volume:

6.81M

Beta:

1.41

Technical Analysis

SMA50:

41.41

SMA100:

41.75

SMA200:

38.23

52-Wk Change:

44.45%

Stock Predictions

Is Cerevel Therapeutics Holdings stock public?
Yes, Cerevel Therapeutics Holdings is a publicly traded company.
What is the Cerevel Therapeutics Holdings stock quote today?
The Cerevel Therapeutics Holdings stock price is 44.39 USD today.
How to buy Cerevel Therapeutics Holdings stock online?
You can buy Cerevel Therapeutics Holdings shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Jul-8	40.75	40.59	40.95	39.91
Jul-9	40.46	40.53	40.56	40.04
Jul-10	40.68	40.93	40.97	40.30
Jul-11	41.23	41.05	41.28	40.66
Jul-12	41.16	40.31	41.16	40.24
Jul-15	40.27	41.90	41.92	40.19
Jul-16	41.90	42.45	42.68	41.73
Jul-17	42.40	42.68	42.74	42.23
Jul-18	42.50	42.70	43.10	42.50
Jul-19	42.74	42.90	42.91	42.53
Jul-22	43.13	43.44	43.61	43.13
Jul-23	43.50	43.40	43.53	43.32
Jul-24	43.37	43.37	43.49	43.33
Jul-25	43.79	44.39	44.54	43.75

Cerevel Therapeutics Holdings Earnings

Cerevel Therapeutics Holdings Earnings Report: Per Share Cerevel Therapeutics Holdings Earnings Q1 Q2 Q3 and Q4 last year and next year.

Cerevel Therapeutics Holdings Forecast Revenue Growth

Cerevel Therapeutics Holdings Stock Analysis: Historical quarterly revenues per share for Cerevel Therapeutics Holdings and historical quarterly revenue growth:

Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.01 per share, and a decrease next year of $0.27 per share.

* Cerevel Therapeutics Holdings stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.